Aquestive Therapeutics News and Activities

Aquestive Therapeutics is owned by Kuraray.

Kuraray is one of the...

• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Kuraray is a company listed under the stock ticker 3405 (JP).

Kuraray has a direct presence in 2 countries.

They are in:

• Chemicals67%
• Pharmaceuticals33%

View the org chart displaying its 19 main executives

Most searched biographies at Aquestive Therapeutics

• Daniel Barber, President, Chief Executive Officer and Director
• Tim Morris, Director
• Santo Costa, Chairman of the Board

Popular executive movements at Aquestive Therapeutics

• Thomas Zalewski will join the company as Chief Legal & Compliance Officer on Apr. 2, 2026  (posted on March 20 2026).
• Lori Braender who is Senior Vice President, General Counsel, will become Company Secretary on Jul. 2, 2026  (posted on March 20 2026).
• Matthew Greenhawt has joined the company as Chief Medical Officer  (posted on February 18 2026).

Click here to view some more movements at Aquestive Therapeutics

Popular executive movements at Kuraray

• Mitsuhiro Nagahama, Member of the Supervisory Board, has left the company  (posted on December 5 2025).
• Fumio Uegaki has joined the company as Executive Officer  (posted on December 5 2025).
• Hiroyuki Shimo, Executive Officer, has left the company  (posted on December 5 2025).

Click here to view some more movements at Kuraray

Create your alert
to follow the executive moves at Aquestive Therapeutics.

Kuraray has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Aquestive Therapeutics

• Press Releases - Aquestive Therapeutics
• Newsroom | Aquestive Therapeutics
• Newsroom | Aquestive Therapeutics
• Newsroom | Aquestive
• Newsroom | Aquestive

Social media about Aquestive Therapeutics

• Aquestive Therapeutics on Wikipedia, Google News & Yahoo Finance
• Aquestive Therapeutics on LinkedIn, X (Twitter) & YouTube